Glenmark Pharma gets USFDA nod for drug for patients on dialysis
The company's stock was trading at Rs 604.25, down 1.66 per cent, on BSE.
The company's stock was trading at Rs 604.25, down 1.66 per cent, on BSE.
Comments Close